Horvath, A., Rainer, F., Bashir, M., Leber, B., Schmerboeck, B., Klymiuk, I., . . . Stadlbauer, V. (2019). Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis. Nature Portfolio.
Cita Chicago Style (17a ed.)Horvath, Angela, et al. Biomarkers for Oralization During Long-term Proton Pump Inhibitor Therapy Predict Survival in Cirrhosis. Nature Portfolio, 2019.
Cita MLA (8a ed.)Horvath, Angela, et al. Biomarkers for Oralization During Long-term Proton Pump Inhibitor Therapy Predict Survival in Cirrhosis. Nature Portfolio, 2019.
Precaución: Estas citas no son 100% exactas.